首页> 外国专利> Composition for amelioration/prevention of adverse side effect in steroid therapy

Composition for amelioration/prevention of adverse side effect in steroid therapy

机译:用于改善/预防类固醇治疗中不良副作用的组合物

摘要

Provided is a composition containing isoleucine, leucine and valine as active ingredients for improving or suppressing side effects associated with a steroid treatment and a composition for suppressing muscular atrophy-related gene. The composition improves or suppresses side effects in a steroid treatment such as muscular atrophy, muscular pain, arthritic pain, impaired glucose tolerance, decreased bone metabolism, impaired immunity, loss of appetite, body weight loss, fatigability and the like, and further suppresses muscular atrophy associated with various diseases. In addition, the composition suppresses muscular atrophy associated with promoted expression of muscular atrophy-related gene associated with glucocorticoid excess or renal failure pathology and the like. Therefore, the composition is effective form improving the QOL of patients.
机译:提供了一种组合物,其包含异亮氨酸,亮氨酸和缬氨酸作为用于改善或抑制与类固醇治疗相关的副作用的活性成分,以及用于抑制肌肉萎缩相关基因的组合物。该组合物改善或抑制类固醇治疗中的副作用,例如肌肉萎缩,肌肉疼痛,关节炎性疼痛,葡萄糖耐量降低,骨代谢降低,免疫力降低,食欲不振,体重减轻,易疲劳性等,并进一步抑制肌肉疾病。与各种疾病相关的萎缩。另外,该组合物抑制与与糖皮质激素过量或肾衰竭病理等相关的肌肉萎缩相关基因的促进表达相关的肌肉萎缩。因此,该组合物是改善患者的生活质量的有效形式。

著录项

  • 公开/公告号EP2606882A1

    专利类型

  • 公开/公告日2013-06-26

    原文格式PDF

  • 申请/专利权人 AJINOMOTO CO. INC.;

    申请/专利号EP20130159694

  • 发明设计人 NISHITANI SHINOBU;TAKEHANA KENJI;

    申请日2007-12-12

  • 分类号A61K31/198;A23L1/305;A61P21;A61P43;

  • 国家 EP

  • 入库时间 2022-08-21 16:29:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号